Stocks
Biogen (BIIB) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 54.1% | 42.6% | 22.6% | 42.8% | 24.2% | 30.8% | ||
| Changes by years, y/y, % | +3pp | -11pp | -20pp | +20pp | -19pp | -13.9% | |||
Biogen. EBITDA margin, %
Biogen. EBITDA margin, changes, pp
Biogen (BIIB) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 1.88% | 25.2% | 31.0% | 39.0% | 28.1% | 30.8% | |
| Changes by years, y/y, % | -37pp | +5pp | +8pp | +10pp | +26pp | |||
| Changes by quarters, q/q, % | -27pp | +23pp | +6pp | +8pp | -11pp | |||
